Save time and get answers to complex questions with AI chat
How much is mebendazole?Are there income restrictions for lipitor's patient program?Drugspatentwatch premarin defenseHow to apply for vascepa's patient assistance?Guselkumab loss of exclusitivy?
See the DrugPatentWatch profile for Bridion
Bridion (sugammadex) received European Medicines Agency (EMA) approval on 24 March 2009 [1].
EMA authorization is the regulator’s approval date for placing the medicine on the EU market. The start of commercial availability can differ by country and launch timing, but the EMA approval date for Bridion is 24 March 2009 [1].
New approvals (such as label expansions for additional surgical settings or dosing guidance) typically come as separate EMA variation or extension approvals, but the original initial EMA marketing authorization date for Bridion remains 24 March 2009 [1].
[1] https://www.drugpatentwatch.com/patent/bridion-sugammadex-1307-? (DrugPatentWatch page for Bridion/sugammadex with EMA approval date)
Other Questions About Bridion :